Learn how PTC Therapeutics developed our spinal muscular atrophy (SMA) therapy from our founder and CEO Stuart Peltz, VP & Head of Group External Affairs and Alliance Management Nikolai Naryshkin, and other members of our dedicated team.
SMA Therapy: A Winding Path to Success
Read Next
Making an Environmental Impact at PTC
At PTC, we strive to be good citizens of the world and make change for a better planet, because...
What You Need to Know About Ferroptosis
Our research efforts at PTC are focused on two scientific platforms – splicing and ferroptosis and inflammation – where...
Honoring International Women’s Day Through Inclusion and Pride
When asked why it’s important to recognize Women’s History Month (WHM) in March, women leaders at PTC agree: WHM...